Matches in SemOpenAlex for { <https://semopenalex.org/work/W137606157> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W137606157 endingPage "8F" @default.
- W137606157 startingPage "26F" @default.
- W137606157 abstract "The availability of selective, potent, orally active and long acting nonpeptide angiotensin II type 1 (AT1) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the renin-angiotensin-aldosterone system at the level of the AT1 receptor that mediates most, if not all, of the important actions of angiotensin II, and avoid the nonspecificity of the angiotensin I converting enzyme inhibitors. Losartan was the first, but by no means remained the only, AT1 receptor antagonist. Numerous other 'sartans' have emerged in the past several years and successfully completed clinical development. With the exception of eprosartan, all others, ie, candesartan, irbesartan, saprisartan, tasosartan, telmisartan, valsartan and zolasartan, are based on medications of losartan's prototypical chemical structure. Among the current AT1 receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280. The mode of (functional) AT1 receptor antagonism has been characterized as surmountable/noncompetitive (losartan, tasosartan, eprosartan) or insurmountable/noncompetitive (candesartan, saprisartan, zolasartan, irbesartan, valsartan, telmisartan, E3174). It is very likely that slow dissociation kinetics from the AT1 receptor underlie insurmountable antagonism. However, competitive or noncompetitive antagonism does not determine the antihypertensive efficacy, but the slow off-rate may extend the occupancy of the AT1 receptor and thereby lengthen the duration of the antihypertensive effect." @default.
- W137606157 created "2016-06-24" @default.
- W137606157 creator A5042814020 @default.
- W137606157 date "1999-11-01" @default.
- W137606157 modified "2023-10-12" @default.
- W137606157 title "Pharmacological properties of angiotensin II receptor antagonists." @default.
- W137606157 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10579749" @default.
- W137606157 hasPublicationYear "1999" @default.
- W137606157 type Work @default.
- W137606157 sameAs 137606157 @default.
- W137606157 citedByCount "25" @default.
- W137606157 countsByYear W1376061572012 @default.
- W137606157 countsByYear W1376061572013 @default.
- W137606157 countsByYear W1376061572018 @default.
- W137606157 crossrefType "journal-article" @default.
- W137606157 hasAuthorship W137606157A5042814020 @default.
- W137606157 hasConcept C104849204 @default.
- W137606157 hasConcept C123915805 @default.
- W137606157 hasConcept C126322002 @default.
- W137606157 hasConcept C134018914 @default.
- W137606157 hasConcept C170493617 @default.
- W137606157 hasConcept C2776885963 @default.
- W137606157 hasConcept C2777383412 @default.
- W137606157 hasConcept C2777387769 @default.
- W137606157 hasConcept C2779716603 @default.
- W137606157 hasConcept C2780036600 @default.
- W137606157 hasConcept C2780259554 @default.
- W137606157 hasConcept C2780288358 @default.
- W137606157 hasConcept C2780708007 @default.
- W137606157 hasConcept C2908929049 @default.
- W137606157 hasConcept C71924100 @default.
- W137606157 hasConcept C84393581 @default.
- W137606157 hasConcept C86811712 @default.
- W137606157 hasConcept C98274493 @default.
- W137606157 hasConceptScore W137606157C104849204 @default.
- W137606157 hasConceptScore W137606157C123915805 @default.
- W137606157 hasConceptScore W137606157C126322002 @default.
- W137606157 hasConceptScore W137606157C134018914 @default.
- W137606157 hasConceptScore W137606157C170493617 @default.
- W137606157 hasConceptScore W137606157C2776885963 @default.
- W137606157 hasConceptScore W137606157C2777383412 @default.
- W137606157 hasConceptScore W137606157C2777387769 @default.
- W137606157 hasConceptScore W137606157C2779716603 @default.
- W137606157 hasConceptScore W137606157C2780036600 @default.
- W137606157 hasConceptScore W137606157C2780259554 @default.
- W137606157 hasConceptScore W137606157C2780288358 @default.
- W137606157 hasConceptScore W137606157C2780708007 @default.
- W137606157 hasConceptScore W137606157C2908929049 @default.
- W137606157 hasConceptScore W137606157C71924100 @default.
- W137606157 hasConceptScore W137606157C84393581 @default.
- W137606157 hasConceptScore W137606157C86811712 @default.
- W137606157 hasConceptScore W137606157C98274493 @default.
- W137606157 hasLocation W1376061571 @default.
- W137606157 hasOpenAccess W137606157 @default.
- W137606157 hasPrimaryLocation W1376061571 @default.
- W137606157 hasRelatedWork W137606157 @default.
- W137606157 hasRelatedWork W1964584012 @default.
- W137606157 hasRelatedWork W2073244528 @default.
- W137606157 hasRelatedWork W2097957153 @default.
- W137606157 hasRelatedWork W2125256919 @default.
- W137606157 hasRelatedWork W2168834946 @default.
- W137606157 hasRelatedWork W2411298426 @default.
- W137606157 hasRelatedWork W3193972101 @default.
- W137606157 hasRelatedWork W330879772 @default.
- W137606157 hasRelatedWork W2292165629 @default.
- W137606157 hasVolume "15 Suppl F" @default.
- W137606157 isParatext "false" @default.
- W137606157 isRetracted "false" @default.
- W137606157 magId "137606157" @default.
- W137606157 workType "article" @default.